Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
seviteronel (5 trials)
Breast Neoplasms (Phase 2)
Breast Neoplasms, Male (Phase 2)
Prostatic Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Trials (5 total)
Trial APIs (1 total)